DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Glucagon (Glucagon) - International Normalised Ratio Increased - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with International Normalised Ratio Increased (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Glucagon where reactions include international normalised ratio increased. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Glucagon side effects in female

Reported by a physician from United States on 2012-03-08

Patient: female

Reactions: Cellulitis, Dyspnoea, Nausea, Skin Ulcer, International Normalised Ratio Increased, Pulmonary Oedema, Drug Interaction

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Saxagliptin
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-08-23

Insulin Lispro
    Dosage: 10 iu, unk
    Indication: Type 2 Diabetes Mellitus

Placebo
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus

Insulin Glargine
    Dosage: 35 iu, unk
    Indication: Type 2 Diabetes Mellitus

Glucagon
    Dosage: 1 mg, unk
    Indication: Type 2 Diabetes Mellitus

Metformin HCL
    Dosage: 2000 mg, unk
    Start date: 2010-08-23

Other drugs received by patient possibly interacting with the suspect drug:
Coumadin
    Dosage: unk

Septra
    Dosage: 1600 mg, unk
    Administration route: Oral
    Start date: 2010-12-05
    End date: 2010-12-11

Other drugs received by patient: Aspirin



Possible Glucagon side effects in 67 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-05

Patient: 67 year old female

Reactions: Cellulitis, Skin Ulcer, International Normalised Ratio Increased, Antibiotic Resistant Staphylococcus Test Positive, Pulmonary Oedema, Drug Interaction, International Normalised Ratio Fluctuation

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Insulin Glargine (Insulin Glargine)
    Dosage: (35 iu), unknown
    Indication: Type 2 Diabetes Mellitus

Coumadin
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication

Metformin HCL
    Dosage: (2000 mg), unknown
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-23

Bactrim
    Dosage: (1600 mg), unknown
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-12-05
    End date: 2010-12-11

Saxagliptin (Saxagliptin)
    Dosage: unknown
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-08-23

Placebo
    Dosage: unknown
    Indication: Type 2 Diabetes Mellitus

Glucagon
    Dosage: (1 mg), unknown
    Indication: Type 2 Diabetes Mellitus

Insulin Lispro (Insulin Lispro)
    Dosage: (10 iu), unknown
    Indication: Type 2 Diabetes Mellitus

Other drugs received by patient: Aspirin



Possible Glucagon side effects in female

Reported by a physician from United States on 2012-03-01

Patient: female

Reactions: Cellulitis, Dyspnoea, Skin Ulcer, International Normalised Ratio Increased, Drug Interaction, Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metformin HCL
    Dosage: 2000 mg, unk
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-08-23

Placebo
    Dosage: unk mg, unk
    Indication: Type 2 Diabetes Mellitus

Insulin Glargine
    Dosage: 35 iu, unk
    Indication: Type 2 Diabetes Mellitus

Saxagliptin
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-08-23

Glucagon
    Dosage: 1 mg, unk
    Indication: Type 2 Diabetes Mellitus

Insulin Lispro
    Dosage: 10 iu, unk
    Indication: Type 2 Diabetes Mellitus

Other drugs received by patient possibly interacting with the suspect drug:
Septra
    Dosage: 1600 mg, unk
    Administration route: Oral
    Start date: 2010-12-05
    End date: 2010-12-11

Warfarin Sodium

Other drugs received by patient: Aspirin



Possible Glucagon side effects in female

Reported by a physician from United States on 2012-02-24

Patient: female

Reactions: Dyspnoea, Cellulitis, Nausea, Skin Ulcer, International Normalised Ratio Increased, Drug Interaction, Pulmonary Oedema

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Metformin HCL
    Dosage: 2000 mg, unk
    Start date: 2010-08-23

Insulin Glargine
    Dosage: 35 iu, unk
    Indication: Type 2 Diabetes Mellitus

Placebo
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus

Glucagon
    Dosage: 1 mg, unk
    Indication: Type 2 Diabetes Mellitus

Saxagliptin
    Dosage: unk
    Indication: Type 2 Diabetes Mellitus
    Start date: 2010-08-23

Insulin Lispro
    Dosage: 10 iu, unk
    Indication: Type 2 Diabetes Mellitus

Other drugs received by patient possibly interacting with the suspect drug:
Septra
    Dosage: 1600 mg, unk
    Administration route: Oral
    Start date: 2010-12-05
    End date: 2010-12-11

Coumadin
    Dosage: unk

Other drugs received by patient: Aspirin

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017